BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
Saved in:
| Title: | BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance. |
|---|---|
| Authors: | Nesic K; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Krais JJ; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; Department of Medicine Division of Oncology, Washington University School of Medicine, St Louis, MO, USA., Wang Y; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Vandenberg CJ; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Patel P; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Cai KQ; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Kwan T; Clovis Oncology Inc., San Francisco, CA, USA., Lieschke E; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Ho GY; School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Barker HE; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Bedo J; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Casadei S; University of Washington, Seattle, WA, USA., Farrell A; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Radke M; University of Washington, Seattle, WA, USA., Shield-Artin K; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Penington JS; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Geissler F; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Kyran E; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Betsch R; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Xu L; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; The University of Queensland, Brisbane, QLD, Australia., Zhang F; Department of Surgery, University of Melbourne, Austin Health, Heidelberg, VIC, Australia., Dobrovic A; Department of Surgery, University of Melbourne, Austin Health, Heidelberg, VIC, Australia., Olesen I; The Andrew Love Cancer Centre, Barwon Health, Geelong, VIC, Australia., Kristeleit R; Department of Oncology, Guys and St Thomas' NHS Foundation Trust, London, UK.; National Institute for Health Research, University College London Hospitals Clinical Research Facility, London, UK., Oza A; Princess Margaret Cancer Center, Toronto, ON, Canada., McNeish I; Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, UK., Ratnayake G; Royal Women's Hospital, Parkville, VIC, Australia., Traficante N; Sir Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Parkville, VIC, Australia., DeFazio A; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Sydney, NSW, Australia.; The Westmead Institute for Medical Research, Sydney, NSW, Australia.; Department of Gynecological Oncology, Westmead Hospital, Western Sydney Local Health District, New South Wales, Australia., Bowtell DDL; Sir Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Parkville, VIC, Australia., Harding TC; Clovis Oncology Inc., San Francisco, CA, USA., Lin K; Clovis Oncology Inc., San Francisco, CA, USA., Swisher EM; University of Washington, Seattle, WA, USA., Kondrashova O; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; The University of Queensland, Brisbane, QLD, Australia., Scott CL; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. scottc@wehi.edu.au.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia. scottc@wehi.edu.au.; Royal Women's Hospital, Parkville, VIC, Australia. scottc@wehi.edu.au.; Sir Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. scottc@wehi.edu.au.; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Parkville, VIC, Australia. scottc@wehi.edu.au.; Department of Obstetrics, Gynecology and Newborn Health, University of Melbourne, Parkville, VIC, Australia. scottc@wehi.edu.au., Johnson N; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA. Neil.Johnson@fccc.edu., Wakefield MJ; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. matthew.wakefield@unimelb.edu.au.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia. matthew.wakefield@unimelb.edu.au.; Department of Obstetrics, Gynecology and Newborn Health, University of Melbourne, Parkville, VIC, Australia. matthew.wakefield@unimelb.edu.au. |
| Corporate Authors: | Australian Ovarian Cancer Study |
| Source: | Molecular cancer [Mol Cancer] 2024 Aug 05; Vol. 23 (1), pp. 158. Date of Electronic Publication: 2024 Aug 05. |
| Publication Type: | Letter |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39103848 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nesic+K%22">Nesic K</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Krais+JJ%22">Krais JJ</searchLink>; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.; Department of Medicine Division of Oncology, Washington University School of Medicine, St Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Vandenberg+CJ%22">Vandenberg CJ</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Patel+P%22">Patel P</searchLink>; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cai+KQ%22">Cai KQ</searchLink>; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kwan+T%22">Kwan T</searchLink>; Clovis Oncology Inc., San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lieschke+E%22">Lieschke E</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Ho+GY%22">Ho GY</searchLink>; School of Clinical Sciences, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Barker+HE%22">Barker HE</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Bedo+J%22">Bedo J</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Casadei+S%22">Casadei S</searchLink>; University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Farrell+A%22">Farrell A</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Radke+M%22">Radke M</searchLink>; University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Shield-Artin+K%22">Shield-Artin K</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Penington+JS%22">Penington JS</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Geissler+F%22">Geissler F</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kyran+E%22">Kyran E</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Betsch+R%22">Betsch R</searchLink>; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Xu+L%22">Xu L</searchLink>; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; The University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Zhang+F%22">Zhang F</searchLink>; Department of Surgery, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Dobrovic+A%22">Dobrovic A</searchLink>; Department of Surgery, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Olesen+I%22">Olesen I</searchLink>; The Andrew Love Cancer Centre, Barwon Health, Geelong, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kristeleit+R%22">Kristeleit R</searchLink>; Department of Oncology, Guys and St Thomas' NHS Foundation Trust, London, UK.; National Institute for Health Research, University College London Hospitals Clinical Research Facility, London, UK.<br /><searchLink fieldCode="AU" term="%22Oza+A%22">Oza A</searchLink>; Princess Margaret Cancer Center, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22McNeish+I%22">McNeish I</searchLink>; Division of Cancer, Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ratnayake+G%22">Ratnayake G</searchLink>; Royal Women's Hospital, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Traficante+N%22">Traficante N</searchLink>; Sir Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22DeFazio+A%22">DeFazio A</searchLink>; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Sydney, NSW, Australia.; The Westmead Institute for Medical Research, Sydney, NSW, Australia.; Department of Gynecological Oncology, Westmead Hospital, Western Sydney Local Health District, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Bowtell+DDL%22">Bowtell DDL</searchLink>; Sir Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Harding+TC%22">Harding TC</searchLink>; Clovis Oncology Inc., San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+K%22">Lin K</searchLink>; Clovis Oncology Inc., San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Swisher+EM%22">Swisher EM</searchLink>; University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Kondrashova+O%22">Kondrashova O</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; The University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Scott+CL%22">Scott CL</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. scottc@wehi.edu.au.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia. scottc@wehi.edu.au.; Royal Women's Hospital, Parkville, VIC, Australia. scottc@wehi.edu.au.; Sir Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. scottc@wehi.edu.au.; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Parkville, VIC, Australia. scottc@wehi.edu.au.; Department of Obstetrics, Gynecology and Newborn Health, University of Melbourne, Parkville, VIC, Australia. scottc@wehi.edu.au.<br /><searchLink fieldCode="AU" term="%22Johnson+N%22">Johnson N</searchLink>; Nuclear Dynamics Program, Fox Chase Cancer Center, Philadelphia, PA, USA. Neil.Johnson@fccc.edu.<br /><searchLink fieldCode="AU" term="%22Wakefield+MJ%22">Wakefield MJ</searchLink>; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. matthew.wakefield@unimelb.edu.au.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia. matthew.wakefield@unimelb.edu.au.; Department of Obstetrics, Gynecology and Newborn Health, University of Melbourne, Parkville, VIC, Australia. matthew.wakefield@unimelb.edu.au. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Australian+Ovarian+Cancer+Study%22">Australian Ovarian Cancer Study</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101147698%22">Molecular cancer</searchLink> [Mol Cancer] 2024 Aug 05; Vol. 23 (1), pp. 158. <i>Date of Electronic Publication: </i>2024 Aug 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101147698 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4598 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214764598%22">14764598 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39103848 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12943-024-02048-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 158 Titles: – TitleFull: BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nesic K – PersonEntity: Name: NameFull: Krais JJ – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Vandenberg CJ – PersonEntity: Name: NameFull: Patel P – PersonEntity: Name: NameFull: Cai KQ – PersonEntity: Name: NameFull: Kwan T – PersonEntity: Name: NameFull: Lieschke E – PersonEntity: Name: NameFull: Ho GY – PersonEntity: Name: NameFull: Barker HE – PersonEntity: Name: NameFull: Bedo J – PersonEntity: Name: NameFull: Casadei S – PersonEntity: Name: NameFull: Farrell A – PersonEntity: Name: NameFull: Radke M – PersonEntity: Name: NameFull: Shield-Artin K – PersonEntity: Name: NameFull: Penington JS – PersonEntity: Name: NameFull: Geissler F – PersonEntity: Name: NameFull: Kyran E – PersonEntity: Name: NameFull: Betsch R – PersonEntity: Name: NameFull: Xu L – PersonEntity: Name: NameFull: Zhang F – PersonEntity: Name: NameFull: Dobrovic A – PersonEntity: Name: NameFull: Olesen I – PersonEntity: Name: NameFull: Kristeleit R – PersonEntity: Name: NameFull: Oza A – PersonEntity: Name: NameFull: McNeish I – PersonEntity: Name: NameFull: Ratnayake G – PersonEntity: Name: NameFull: Traficante N – PersonEntity: Name: NameFull: DeFazio A – PersonEntity: Name: NameFull: Bowtell DDL – PersonEntity: Name: NameFull: Harding TC – PersonEntity: Name: NameFull: Lin K – PersonEntity: Name: NameFull: Swisher EM – PersonEntity: Name: NameFull: Kondrashova O – PersonEntity: Name: NameFull: Scott CL – PersonEntity: Name: NameFull: Johnson N – PersonEntity: Name: NameFull: Wakefield MJ IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 08 Text: 2024 Aug 05 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1476-4598 Numbering: – Type: volume Value: 23 – Type: issue Value: 1 Titles: – TitleFull: Molecular cancer Type: main |
| ResultId | 1 |